# Bariatric Surgery Devices Market

> Bariatric Surgery Devices Market Research Report: Size, Share, Trend Analysis By Types (Minimally Invasive Surgical Devices, Non-invasive Surgical Devices) By Procedure (Sleeve Gastrectomy, Gastric Bypass, Revision Surgery, Adjustable Gastric Band), By End Users (Hospitals, Specialty Centers, Ambulatory Surgical Centers), and By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth Outlook & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 6.12%
- **2024:** $ 2,472.6 Million
- **2025:** $ 2,623.93 Million
- **2035:** $ 4,752.63 Million
- **Key Players:** Medtronic (US), Johnson & Johnson (US), Boston Scientific (US), Stryker (US), B. Braun Melsungen AG (DE), Conmed Corporation (US), Intuitive Surgical (US), Hologic (US), Ethicon (US)

**Report ID:** MRFR/MED/4649-CR · **Pages:** 123 · **Author:** Rahul Gotadki · **Last Updated:** April 24, 2026

**URL:** https://www.marketresearchfuture.com/reports/bariatric-surgery-devices-market-6107

---

## Market Summary

## **Bariatric Surgery Devices Market Overview**

As per MRFR analysis, the Bariatric Surgery Devices Market Size was estimated at 2.47 (USD Billion) in 2024. The Bariatric Surgery Devices Market Industry is expected to grow from 2.62 (USD Billion) in 2025 to 4.48 (USD Billion) till 2034, at a CAGR (growth rate) is expected to be around 6.12% during the forecast period (2025 - 2034).

Major factors driving the market for bariatric surgical devices include the rising incidence of adult obesity brought on by altered lifestyle patterns and excessive calorie consumption. 

The demand for bariatric operations is also anticipated to rise over the forecast period due to increased government backing and growing public awareness of the market's unhealthy food and beverage offerings and how they affect BMI, thus driving the market growth of the Bariatric Surgery Devices. These are just a few of the market drivers that are driving the market.

Source Secondary Research, Primary Research, _Market Research Future_ Database and Analyst Review

**In August 2022**: Standard Bariatrics was announced as being purchased by Teleflex for $170 million in upfront cash and up to an additional $130 million if certain commercial milestones are met.

**January 2022**: The first Complete Robotic Bariatric surgery was conducted at Apollo Hospital Hyderabad on Sunday which was a first-of-its-kind operation in Telugu states. The surgery involved a 180 kg weighing Somali woman aged 40 years old called Hibibo Abdulle Mohamed, who had health challenges.

Standard Bariatrics, Inc. achieved an important milestone on this journey when their Titan SGS surgical stapler technology hit its one-thousandth successful clinical case in January 2022. As a result, there have been improved outcomes with respect to the customization of Titan SGS into bariatric operations, leading to reduced length of procedure and better results.

Additionally, it should be noted that Olympus introduced POWERSEAL advanced bipolar surgical energy devices in September 2021 to strengthen its surgical portfolio. It can be employed for various types of surgical interventions, including bariatric surgeries.

Similarly, Ethicon launched ENSEAL X1 Curved Jaw Tissue Sealer for colorectal, gynecological, bariatric surgery and thoracic procedures, among others, as part of Johnson & Johnson Medical Devices Companies’ portfolio in June 2021. These major players have also made new product launches using new closing devices, thereby increasing the growth rate within the studied market.

For example, Standard Bariatrics announced the introduction of Titan SGS stapling technology designed specifically for bariatric sleeve surgery in May 2021. Also, it has cleared FDA regulations. These major players have also made new product launches using new closing devices, thereby increasing the growth rate within the studied market.

## **Bariatric Surgery Devices Market Trends**

The primary driver of the market is the rising prevalence of adult obesity and the increased operational effectiveness of cutting-edge robotic technologies. The (NICE) National Institute for Health and Care Excellence recommended that bariatric surgery be considered earlier for persons with diabetes mellitus than lifestyle changes and medication. In the upcoming years, these innovations are anticipated to accelerate market expansion. Additional projected market expansion drivers include expanding reimbursement coverage and sponsored bariatric procedures by regional governments of developed countries.

Intragastric balloons were added to the American Society for Metabolic and Bariatric Surgery's (ASMBS) list of suggested devices for use during bariatric surgeries in February 2018. Three of these devices were approved in Europe, and the FDA also approved these devices in the US in 2015–16. It is predicted that these endorsements and recommendations will significantly accelerate market expansion. Thus, this factor is driving the market CAGR.

An analysis of 2016 WHO data shows that 1.9 billion people are overweight, of which 650 million are obese. Around 13% of people over the age of 18 and 41 million children under the age of 5 are fat, according to statistics. The American Heart Association predicts that by 2030, the entire cost of medical care might increase to USD 957 billion from USD 861 billion. The government is acting to minimize the prevalence of obesity and its long-term chronic disorders because of the enormous healthcare spending.

The District of Columbia and 50 states received funding from the Centers for Disease Control and Prevention (CDC) in 2017 to improve initiatives. Thus, it is anticipated that this aspect will accelerate Bariatric Surgery Devices market revenue globally.

## **Bariatric Surgery Devices Market Segment Insights**

### **Bariatric Surgery Devices Type Insights**

The market segments of Bariatric Surgery Devices, based on type includes, minimally invasive surgical devices, non-invasive surgical devices. The minimally invasive surgical devices segment held the majority share in 2022 in the Bariatric Surgery Devices market data. The popularity of this minimally invasive procedure for this surgery has increased over the past ten years, along with the growing acceptability of laparoscopic surgery. With a smaller incision, laparoscopic surgery is more convenient for patients. Due to this procedure, the stomach is reduced to a tiny pouch, and little food may enter the small intestine.

The small intestine is bypassed, which reduces nutrition and fat absorption and aids in weight loss.

### **Bariatric Surgery Devices Procedure Insights**

The Bariatric Surgery Devices market segmentation, based on procedure includes sleeve gastrectomy, gastric bypass, revision surgery, adjustable gastric band. The sleeve gastrectomy segment dominated the market growth in 2022 and is projected to be the faster-growing segment during the forecast period, 2023-2032. As sleeve gastrectomy was recently approved by the FDA and required no incisions, this market is anticipated to expand at the fastest rate throughout the projected period. In recent years, this process has undergone several changes.

The majority (42.1%) of the 179,000 procedures conducted, according to the American Society for Metabolic and Bariatric Surgery (ASMBS), were sleeve gastrectomy, followed by gastric bypasses, hence contributing in the market growth of the Bariatric Surgery Devices.

**Figure 2 Bariatric Surgery Devices Market, by Procedure, 2022 & 2032 (USD Billion)**

**_Source Secondary Research, Primary Research, MRFR Database and Analyst Review_**

### **Bariatric Surgery Devices End-User Insights**

The market segmentation of Bariatric Surgery Devices, based on end-user includes, hospitals, specialty centers, ambulatory surgical centers. The hospitals segment held the majority share in 2022 in the Bariatric Surgery Devices market data. This is related to the expanding usage of bariatric surgery devices in hospitals and the accessibility of affordable medical care in clinics. The increased number of hospital and ophthalmology clinic mergers and acquisitions is expected to enhance the need for new installations in the future years.

### **Bariatric Surgery Devices Regional Insights**

By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. North America Bariatric Surgery Devices market accounted for USD 1.007 billion in 2022 with a share of around 45.80% and is expected to exhibit a significant CAGR growth during the study period. The industry participants are conducting studies to assess the effectiveness of their surgeries to treat obesity due to rising obesity rates and significant government financing.

For instance, bariatric procedures previously covered by Medicare for people with BMIs of 40 or higher were changed to cover anyone with BMIs of 30 or higher. Many people who were fat and couldn't afford the high costs of surgery, doctors, and hospitals benefited from this development. New product development, partnerships, partnerships, expansions, mergers, and acquisitions are the main strategies used by the organisations in the market.

Further, the major countries studied in the market report are The U.S, Canada, Germany, France, UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

**Figure 3 BARIATRIC SURGERY DEVICES MARKET SHARE BY REGION 2022 (%)**

**_Source Secondary Research, Primary Research, MRFR Database and Analyst Review_**

Europe Bariatric Surgery Devices market accounts for the second-largest market share. Ireland leads the way in the frightening rise of obesity across Europe. The WHO study on the European Modelling Obesity Project detailed the different interventions and financial burdens on healthcare systems associated with obesity if it is not treated. As a result, the government is sponsoring numerous academic institutions to develop novel approaches. Moreover, UK market of Bariatric Surgery Devices held the largest market share, and the Germany market of Bariatric Surgery Devices was the fastest growing market in the region.

Asia Pacific Bariatric Surgery Devices Market is expected to grow at the fastest CAGR from 2022 to 2030. This can be attributed to many obese people and rising medical tourism due to surgery performed at reasonable prices. The Procedures, which cost USD 25,000 in the US, are available in Asia Pacific nations for USD 12,000. To examine the variables connected to obesity in this country, even industrial firms have expanded their research facilities there.

Further, the China market of Bariatric Surgery Devices held the largest market share, and the India market of Bariatric Surgery Devices was the fastest-growing market in the region.

**Bariatric Surgery Devices Key Market Players & Competitive Insights**

Major market players are spending a lot of money on R&D to increase their product lines, which will help the market of Bariatric Surgery Devices grow even more. Market participants are also taking a range of strategic initiatives to grow their worldwide footprint, with key market developments such as new product launches, mergers and acquisitions, contractual agreements, increased investments, and collaboration with other organizations. Competitors in the Bariatric Surgery Devices industry must offer cost-effective items to expand and survive in an increasingly competitive and rising market environment.

One of the primary business strategies adopted by manufacturers in the  Bariatric Surgery Devices industry to benefit clients and expand the market sector is to manufacture locally to reduce operating costs. In recent years, Bariatric Surgery Devices industry has provided medicine with some of the most significant benefits. The Bariatric Surgery Devices market major player such Medtronic, TransEnterix Surgical Inc., Johnson & Johnson Services Inc., Apollo Endosurgery Inc.,   ReShape Lifesciences Inc.

A clinical-stage medical device firm is GI Dynamics Inc. It is developing and marketing a medical device called EndoBarrier designed to treat people with type 2 diabetes and obesity. To explore end barrier-induced changes in bile acid, which regulates glucose and energy balance, GI Dynamics Inc. and GSK partnered.

A Johnson & Johnson subsidiary is Ethicon, Inc., which they acquired to broaden and diversify the Johnson & Johnson product portfolio; it was established as a distinct business under the Johnson & Johnson brand in 1949. Since 1887, Ethicon has been producing surgical sutures and tools for wound closure. Ethicon invested about $3.2 million. The money was spent researching how weight loss surgery affects Type 2 diabetes and obesity.

**Key Companies in the market of Bariatric Surgery Devices includes**

**Bariatric Surgery Devices Industry Developments**

**August 2022 **As part of the agreement, Teleflex agreed to pay USD 170 million in cash up front and USD 130 million more if certain commercial targets were achieved.

**January 2022 **Apollo Hospital in Hyderabad claimed it had carried out the first Full Robotic Bariatric surgery in Telugu. Hibibo Abdulle Mohamed, a 40-year-old Somalian who weighed 180 kg and had several health issues, underwent the procedure.

## **Bariatric Surgery Devices Market Segmentation**

### **Bariatric Surgery Devices Type Outlook (USD Billion, 2018-2030)**

### **Bariatric Surgery Devices Procedure Outlook (USD Billion, 2018-2030)**

### **Bariatric Surgery Devices End-User Outlook (USD Billion, 2018-2030)**

### **Bariatric Surgery Devices Regional Outlook (USD Billion, 2018-2030)**

## Market Drivers

### Rising Obesity Rates

The increasing prevalence of obesity globally serves as a primary driver for the Global Bariatric Surgery Devices Market Industry. According to the World Health Organization, obesity rates have nearly tripled since 1975, with more than 1.9 billion adults classified as overweight. This alarming trend necessitates effective weight management solutions, leading to a growing demand for bariatric surgery devices. In 2024, the market is projected to reach 2.47 USD Billion, reflecting the urgent need for surgical interventions to combat obesity-related health issues. As awareness of obesity's health implications rises, the market is likely to expand further.

### Technological Advancements

Technological innovations in bariatric surgery devices significantly enhance their effectiveness and safety, thereby propelling the Global Bariatric Surgery Devices Market Industry. Minimally invasive techniques, such as laparoscopic surgery, have gained traction, resulting in shorter recovery times and reduced complications. The introduction of advanced surgical instruments and robotic-assisted systems has further improved surgical outcomes. These advancements not only attract more patients but also encourage healthcare providers to adopt these technologies. As a result, the market is expected to grow, with projections indicating a rise to 4.75 USD Billion by 2035, driven by ongoing technological improvements.

### Growing Awareness and Acceptance

The rising awareness and acceptance of bariatric surgery as a viable treatment option for obesity significantly influence the Global Bariatric Surgery Devices Market Industry. Educational campaigns and advocacy efforts by health organizations have helped to destigmatize surgical weight loss, encouraging individuals to consider surgical options. This shift in perception is crucial, as it leads to increased patient inquiries and consultations regarding bariatric procedures. As more patients seek surgical interventions, the market is poised for growth, with an anticipated increase in demand for various bariatric devices. This trend underscores the importance of education in driving market expansion.

### Increasing Healthcare Expenditure

Rising healthcare expenditure across various regions contributes to the growth of the Global Bariatric Surgery Devices Market Industry. Governments and private sectors are investing more in healthcare infrastructure, which includes funding for obesity treatment programs. This trend is particularly evident in developed nations, where healthcare budgets are expanding to accommodate advanced surgical procedures. As healthcare systems allocate more resources to combat obesity, the demand for bariatric surgery devices is likely to increase. This financial commitment may lead to a compound annual growth rate of 6.13% from 2025 to 2035, reflecting the growing recognition of obesity as a critical public health issue.

### Regulatory Support and Guidelines

Regulatory support and the establishment of guidelines for bariatric surgery play a pivotal role in shaping the Global Bariatric Surgery Devices Market Industry. Health authorities are increasingly recognizing the necessity of surgical interventions for obesity management, leading to the development of standardized protocols and approval processes for bariatric devices. This regulatory framework not only ensures patient safety but also fosters innovation within the industry. As regulatory bodies continue to endorse bariatric surgery, the market is likely to experience sustained growth, driven by the introduction of new devices and techniques that meet established safety and efficacy standards.

## Future Outlook

The Bariatric Surgery Devices Market is projected to grow at a 6.12% CAGR from 2025 to 2035, driven by rising obesity rates, technological advancements, and increasing healthcare expenditure.

**New opportunities:**

- Development of AI-driven surgical planning software Expansion of telehealth services for pre- and post-operative care Partnerships with insurance providers for coverage expansion

By 2035, the market is expected to achieve substantial growth, reflecting evolving healthcare dynamics.

## Segment Insights

### By Application: Gastric Bypass (Largest) vs. Sleeve Gastrectomy (Fastest-Growing)

The Bariatric Surgery Devices Market is characterized by a diverse application spectrum, with Gastric Bypass leading as the dominant procedure due to its long-established efficacy and popularity among patients seeking significant weight loss. Sleeves Gastrectomy follows closely, gaining traction as a preferred choice for both its safety profile and the absence of foreign objects. Other procedures like Adjustable Gastric Banding and Biliopancreatic Diversion play smaller roles, while [Intragastric Balloon](https://www.marketresearchfuture.com/reports/intragastric-balloon-market-41755) is emerging, especially among patients looking for non-surgical options.

Bariatric Surgery: Gastric Bypass (Dominant) vs. Sleeve Gastrectomy (Emerging)

Gastric Bypass remains the dominant procedure in the bariatric landscape due to its substantial weight loss results and metabolic benefits. Its proven efficacy drives patient choice and surgeon recommendation, solidifying its market position. On the other hand, Sleeve Gastrectomy is rapidly emerging, particularly appealing to younger demographics and patients prioritizing minimally invasive techniques. This procedure is largely favored for its practical advantages, including a lower complication rate and quicker recovery time. As guidelines evolve and the acceptance of these methods continues, both procedures will likely maintain significant shares in the market, albeit with differential impacts driven by patient preferences and advancements in surgical techniques.

### By Device Type: Surgical Staplers (Largest) vs. Endoscopes (Fastest-Growing)

The Bariatric Surgery Devices Market is characterized by a complex landscape where Surgical Staplers account for the largest share among various device types. This segment has established a solid foothold due to its critical role in facilitating effective surgical procedures, thus becoming a preferred choice among surgeons. Following closely, Endoscopes are emerging as a significant contender, gaining traction due to their minimally invasive nature and the rising demand for less traumatic surgical solutions. Growth trends indicate that advancements in technology and increasing patient awareness are pivotal drivers for the Bariatric Surgery Devices Market. Endoscopes, in particular, are witnessing rapid acceleration as they integrate newer imaging technologies, enhancing surgical precision. Additionally, the overall rise in obesity-related health issues globally has led to an increased focus on innovative devices that improve surgical outcomes and patient recovery times.

Surgical Staplers (Dominant) vs. Implantable Devices (Emerging)

Surgical Staplers are recognized as the dominant force in the Bariatric Surgery Devices Market due to their reliability and effectiveness in various surgical procedures. These devices facilitate the joining of tissues, making them a critical component for achieving optimal surgical results. On the other hand, Implantable Devices are positioned as an emerging segment, gaining attention for their role in long-term weight management solutions. While Surgical Staplers have established market trust, Implantable Devices are innovating with various mechanisms that promote sustained weight loss. This duality showcases how established efficacy and new technologies coexist, enriching the overall market landscape.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Bariatric Surgery Devices Market, hospitals dominate the end-user segment, capturing the largest share of the market due to their advanced infrastructure and comprehensive healthcare services. Ambulatory surgical centers, on the other hand, are rapidly gaining attention and are becoming a significant player owing to reduced surgery costs and shorter recovery times associated with outpatient procedures. Specialty clinics and research institutions also play critical roles, but they represent smaller market shares compared to the primary segments of hospitals and surgical centers.

Ambulatory Surgical Centers: Fastest-Growing vs. Specialty Clinics: Emerging

Ambulatory surgical centers (ASCs) are emerging as a fast-growing segment in the Bariatric Surgery Devices Market, driven by a surge in demand for outpatient procedures that facilitate quick recovery. These centers offer specialized bariatric surgery services with lower operational costs, making them increasingly attractive to both surgeons and patients. In contrast, specialty clinics focus on niche bariatric procedures but remain a smaller player in the market. They tend to offer highly personalized care and post-operative support, catering to specific patient needs, yet may lack the extensive resources of larger hospitals. The growth trajectory of ASCs is supported by technological advancements and increasing patient awareness of obesity treatment options.

### By Patient Demographics: Obese Adults (Largest) vs. Patients Seeking Weight Loss Solutions (Fastest-Growing)

In the Bariatric Surgery Devices Market, the segment of Obese Adults holds the largest share, primarily due to the increasing prevalence of obesity in the adult population. This demographic, often defined as individuals with a Body Mass Index (BMI) of 30 or higher, is a major driver for demand as more adults seek surgical interventions to manage their weight. Following closely are Patients Seeking Weight Loss Solutions, who are showing a rapid increase in numbers as awareness and acceptance of bariatric surgery gain traction. This segment is effectively capitalizing on the burgeoning lifestyle and wellness trends, making it a significant contributor to the market landscape.

Obese Adults (Dominant) vs. Patients with Comorbidities (Emerging)

Obese Adults represent the dominant segment in the Bariatric Surgery Devices Market, characterized by a significant need for surgical interventions due to lifestyle-related conditions. This group typically experiences a range of health issues, including diabetes and hypertension, necessitating more aggressive weight management strategies. On the other hand, Patients with Comorbidities is an emerging segment that is gaining traction as healthcare providers recognize the urgent need to treat obesity-related diseases that may complicate other health conditions. This demographic often includes patients suffering from multiple comorbidities, thereby increasing the propensity for surgical solutions as part of comprehensive care strategies. Consequently, both segments reflect distinct yet intertwined trends influencing the overall market dynamics.

### By Surgical Technique: Laparoscopic Surgery (Largest) vs. Robotic Surgery (Fastest-Growing)

In the Bariatric Surgery Devices Market, the distribution of market share among surgical techniques reveals Laparoscopic Surgery as the dominant approach, commanding a significant share. It is favored due to its minimally invasive nature, leading to shorter recovery times and reduced complications for patients. Open Surgery, while still performing a notable number of procedures, is gradually being overshadowed by the advancement in laparoscopic technologies. Robotic Surgery, although currently holding a smaller segment of the market, is gaining traction rapidly among surgeons due to enhanced precision and control.

Surgical Technique: Laparoscopic Surgery (Dominant) vs. Robotic Surgery (Emerging)

Laparoscopic Surgery stands out in the Bariatric Surgery Devices Market as a preferred choice due to its ability to minimize patient trauma while maximizing procedural efficiency. Surgeons appreciate the reduced postoperative pain and quicker recovery associated with this technique. Meanwhile, Robotic Surgery, though less established, is emerging as a game-changer. The use of robotic systems enhances surgical precision and allows for complex procedures to be carried out with great accuracy. As more healthcare facilities adopt robotic systems, the demand is expected to rise, positioning Robotic Surgery as a futuristic solution that is carving its niche in bariatric practices.

## Regional Market Share Analysis

### North America : Market Leader in Innovation

North America is the largest market for bariatric surgery devices, holding a significant share of 1230.0M in 2024. The region's growth is driven by rising obesity rates, increasing awareness of weight management, and advancements in surgical technologies. Regulatory support from agencies like the FDA has also catalyzed market expansion, ensuring safety and efficacy in new devices. The demand for minimally invasive procedures is further propelling market growth, as patients seek quicker recovery times and reduced hospital stays. The competitive landscape in North America is robust, featuring key players such as Medtronic, Johnson & Johnson, and Intuitive Surgical. These companies are at the forefront of innovation, developing cutting-edge technologies that enhance surgical outcomes. The U.S. remains the leading country, with a well-established healthcare infrastructure and high patient demand for bariatric procedures. This competitive environment fosters continuous improvement and investment in research and development, solidifying North America's position as a market leader.

### Europe : Emerging Market with Potential

Europe's bariatric surgery devices market is valued at 750.0M, reflecting a growing awareness of obesity-related health issues. The region is witnessing an increase in demand for surgical interventions, driven by rising obesity rates and supportive healthcare policies. Regulatory frameworks across European countries are evolving to facilitate the approval of innovative devices, enhancing patient access to advanced surgical options. The focus on preventive healthcare is also contributing to market growth, as governments prioritize obesity management. Leading countries in Europe include Germany, France, and the UK, where healthcare systems are increasingly adopting bariatric procedures. The competitive landscape features prominent players like B. Braun Melsungen AG and Ethicon, which are investing in new technologies to improve surgical outcomes. The presence of established healthcare networks and a growing number of specialized clinics are further driving the market, positioning Europe as a significant player in The Bariatric Surgery Devices.

### Asia-Pacific : Rapidly Growing Market

The Asia-Pacific region is experiencing rapid growth in the bariatric surgery devices market, valued at 400.0M. This growth is fueled by increasing obesity rates, changing lifestyles, and rising disposable incomes. Countries like China and India are witnessing a surge in demand for bariatric procedures, driven by a growing awareness of obesity-related health risks. Regulatory bodies are also becoming more supportive, streamlining approval processes for new devices, which is essential for market expansion. In this region, key players such as Boston Scientific and Stryker are actively expanding their presence, focusing on innovative solutions tailored to local needs. The competitive landscape is evolving, with an increasing number of healthcare facilities offering bariatric services. As the region continues to develop its healthcare infrastructure, the demand for advanced surgical devices is expected to rise, making Asia-Pacific a crucial market for future growth.

### Middle East and Africa : Emerging Market Opportunities

The Middle East and Africa (MEA) bariatric surgery devices market is valued at 92.6M, reflecting emerging opportunities in this region. The rising prevalence of obesity and related health issues is driving demand for surgical interventions. Governments are increasingly recognizing the importance of addressing obesity as a public health concern, leading to supportive policies and initiatives. The market is also benefiting from the growing number of healthcare facilities offering bariatric services, enhancing patient access to treatment. Leading countries in the MEA region include South Africa and the UAE, where healthcare systems are evolving to meet the rising demand for bariatric procedures. The competitive landscape features both local and international players, with companies like Conmed Corporation making significant inroads. As awareness of obesity management grows, the MEA region is poised for substantial growth in the bariatric surgery devices market, presenting opportunities for investment and innovation.

## Competitive Benchmarking

The Bariatric Surgery Devices Market is currently characterized by a dynamic competitive landscape, driven by increasing obesity rates and a growing awareness of surgical options. Key players such as Medtronic (US), Johnson & Johnson (US), and Boston Scientific (US) are strategically positioned to leverage innovation and technological advancements. Medtronic (US) focuses on enhancing its product portfolio through continuous innovation, while Johnson & Johnson (US) emphasizes strategic partnerships to expand its market reach. Boston Scientific (US) is actively pursuing mergers and acquisitions to bolster its capabilities in minimally invasive surgical devices, thereby shaping a competitive environment that is increasingly reliant on technological differentiation and strategic collaborations. In terms of business tactics, companies are localizing manufacturing to reduce costs and optimize supply chains, which is particularly crucial in a moderately fragmented market. The competitive structure is influenced by the collective actions of these key players, who are increasingly adopting strategies that enhance operational efficiency and responsiveness to market demands. This collective influence fosters a competitive atmosphere where innovation and strategic positioning are paramount. In November 2025, Medtronic (US) announced the launch of a new line of advanced bariatric surgical instruments designed to improve patient outcomes and reduce recovery times. This strategic move is significant as it not only enhances Medtronic's product offerings but also reinforces its commitment to innovation in the bariatric surgery space, potentially increasing its market share. In October 2025, Johnson & Johnson (US) entered into a partnership with a leading telehealth provider to integrate digital health solutions into its bariatric surgery offerings. This collaboration is indicative of a broader trend towards digital transformation in healthcare, allowing for improved patient monitoring and engagement, which could enhance surgical outcomes and patient satisfaction. In September 2025, Boston Scientific (US) completed the acquisition of a smaller firm specializing in robotic-assisted surgical technologies. This acquisition is strategically important as it positions Boston Scientific to compete more effectively in the growing market for robotic-assisted bariatric procedures, aligning with the increasing demand for minimally invasive surgical options. As of December 2025, the competitive trends in the Bariatric Surgery Devices Market are increasingly defined by digitalization, sustainability, and the integration of artificial intelligence (AI). Strategic alliances are becoming more prevalent, as companies recognize the need to collaborate to enhance their technological capabilities. Looking ahead, competitive differentiation is likely to evolve from traditional price-based competition to a focus on innovation, advanced technology, and supply chain reliability, reflecting the changing dynamics of the market.

## Recent News & Developments

**August 2022 **As part of the agreement, Teleflex agreed to pay USD 170 million in cash up front and USD 130 million more if certain commercial targets were achieved.

**January 2022 **Apollo Hospital in Hyderabad claimed it had carried out the first Full Robotic Bariatric surgery in Telugu. Hibibo Abdulle Mohamed, a 40-year-old Somalian who weighed 180 kg and had several health issues, underwent the procedure.

## Report Scope

| MARKET SIZE 2024 | 2472.6(USD Million) |
| --- | --- |
| MARKET SIZE 2025 | 2623.93(USD Million) |
| MARKET SIZE 2035 | 4752.63(USD Million) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 6.12% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Million |
| Key Companies Profiled | Medtronic (US), Johnson & Johnson (US), Boston Scientific (US), Stryker (US), B. Braun Melsungen AG (DE), Conmed Corporation (US), Intuitive Surgical (US), Hologic (US), Ethicon (US) |
| Segments Covered | Application, Device Type, End User, Patient Demographics, Surgical Technique |
| Key Market Opportunities | Integration of advanced minimally invasive techniques enhances patient outcomes in the Bariatric Surgery Devices Market. |
| Key Market Dynamics | Technological advancements and regulatory changes drive innovation and competition in the Bariatric Surgery Devices Market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the projected market valuation for the Bariatric Surgery Devices Market in 2035?**
A: The projected market valuation for the Bariatric Surgery Devices Market in 2035 is 4752.63 USD Million.

**Q: What was the overall market valuation for the Bariatric Surgery Devices Market in 2024?**
A: The overall market valuation for the Bariatric Surgery Devices Market in 2024 was 2472.6 USD Million.

**Q: What is the expected CAGR for the Bariatric Surgery Devices Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Bariatric Surgery Devices Market during the forecast period 2025 - 2035 is 6.12%.

**Q: Which companies are considered key players in the Bariatric Surgery Devices Market?**
A: Key players in the Bariatric Surgery Devices Market include Medtronic, Johnson & Johnson, Boston Scientific, and Stryker.

**Q: What are the main applications of bariatric surgery devices and their market valuations?**
A: The main applications include Sleeve Gastrectomy valued at 1600.0 USD Million and Gastric Bypass valued at 1200.0 USD Million.

**Q: How do the market valuations for different types of bariatric surgery devices compare?**
A: Surgical Instruments are valued at 1000.0 USD Million, while Implantable Devices reach 1200.0 USD Million.

**Q: What is the market valuation for bariatric surgery devices used in hospitals?**
A: The market valuation for bariatric surgery devices used in hospitals is 1980.52 USD Million.

**Q: Which patient demographics are driving the Bariatric Surgery Devices Market?**
A: Obese adults represent a significant segment, with a market valuation of 2380.0 USD Million.

**Q: What surgical techniques are utilized in the Bariatric Surgery Devices Market and their valuations?**
A: Laparoscopic Surgery is valued at 2400.0 USD Million, indicating its prominence in the market.

**Q: What is the market valuation for ambulatory surgical centers in the Bariatric Surgery Devices Market?**
A: The market valuation for ambulatory surgical centers is 990.26 USD Million.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/bariatric-surgery-devices-market-6107*